Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pituitary Diseases × Diazoxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Endocrine 1 CNS 1

Conditions

Pituitary Diseases 1 Obesity 1 Neoplasms 1 Hyperinsulinism 1 Craniopharyngioma 1

Interventions

Mifepristone 3 Corlux 3 Thyrotropin-Releasing Hormone 1 Surgical Procedures, Operative 1 Radiotherapy 1 LY2940680 1 Hydrocortisone 1 Human Growth Hormone 1 Diazoxide 1 Dexamethasone 1 Anesthesia, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00306683 2011-02-18

Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

CNSEndocrineOther

Craniopharyngioma, Hyperinsulinism, Neoplasms, Obesity, Pituitary Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡